Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naive cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study

被引：0
|
作者：
Giocanti-Auregan, Audrey [1 ]
Yang, Chang-Hao [2 ]
Donati, Simone [3 ]
Allmeier, Helmut [4 ]
Machewitz, Tobias [5 ]
Rittenhouse, Kay D. [6 ]
Hoerauf, Hans [7 ]
机构：
[1] Sorbonne Paris Nord Univ, Hop Avicenne, Bobigny, France
[2] Natl Taiwan Univ Hosp, Dept Ophthalmol & Coll Med, Taipei, Taiwan
[3] Univ Insubria, Dept Med & Surg, Varese, Italy
[4] Bayer Consumer Care AG, Basel, Switzerland
[5] Bayer AG, Berlin, Germany
[6] Bayer US LLC, Whippany, NJ USA
[7] Univ Med Gottingen, Augenklin, Gottingen, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1762
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
    Lotery, A. J.
    Regnier, S.
    EYE, 2015, 29 (03) : 380 - 387
  • [42] Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion that is Refractory to Intravitreal Anti-VEGF compared to treatment naive Edema
    Pielen, Amelie
    Boehringer, Daniel
    Heinzelmann, Sonja U.
    Ness, Thomas
    Junker, Bernd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [43] Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion
    Wibbelsman, Turner D.
    Calem, Daniel B.
    Obeid, Anthony
    Mellen, Phoebe L.
    Konkoly, Michelle A.
    Velez, Michael R.
    Sioufi, Kareem
    Borkar, Durga S.
    Pandit, Ravi
    Klufas, Michael A.
    Hsu, Jason
    Regillo, Carl
    Ho, Allen C.
    Gupta, Omesh P.
    Spirn, Marc J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [44] Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: One-year results
    Beutel J.
    Ziemssen F.
    Lüke M.
    Partsch M.
    Bartz-Schmidt K.-U.
    Gelisken F.
    International Ophthalmology, 2010, 30 (1) : 15 - 22
  • [45] Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study
    Korobelnik, Jean-Francois
    Larsen, Michael
    Eter, Nicole
    Bailey, Clare
    Wolf, Sebastian
    Schmelter, Thomas
    Allmeier, Helmut
    Chaudhary, Varun
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 227 : 106 - 115
  • [46] Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion One-Year Results of the Phase 3 GALILEO Study
    Korobelnik, Jean-Francois
    Holz, Frank G.
    Roider, Johann
    Ogura, Yuichiro
    Simader, Christian
    Schmidt-Erfurth, Ursula
    Lorenz, Katrin
    Honda, Miki
    Vitti, Robert
    Berliner, Alyson J.
    Hiemeyer, Florian
    Stemper, Brigitte
    Zeitz, Oliver
    Sandbrink, Rupert
    OPHTHALMOLOGY, 2014, 121 (01) : 202 - 208
  • [47] Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion 52-Week Results of the VIBRANT Study
    Clark, W. Lloyd
    Boyer, David S.
    Heier, Jeffrey S.
    Brown, David M.
    Haller, Julia A.
    Vitti, Robert
    Kazmi, Husain
    Berliner, Alyson J.
    Erickson, Kristine
    Chu, Karen W.
    Soo, Yuhwen
    Cheng, Yenchieh
    Campochiaro, Peter A.
    OPHTHALMOLOGY, 2016, 123 (02) : 330 - 336
  • [48] Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naive branch retinal vein occlusion
    Huang, Yu-Te
    Lin, Chun-Ju
    Chen, Huan-Sheng
    Tien, Peng-Tai
    Lai, Chun-Ting
    Hsia, Ding-Yi
    Lin, Jane-Ming
    Chen, Wen-Lu
    Tsai, Yi-Yu
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [49] Safety and Efficacy of Two or More Dexamethasone Intravitreal Implants in Treatment-Naive Patients with Macular Edema Due to Retinal Vein Occlusion
    Singer, Michael
    Capone, Antonio
    Dugel, Pravin U.
    Dreyer, Richard F.
    Dodwell, David G.
    Roth, Daniel B.
    Shi, Rui
    Walt, John G.
    Scott, Lanita C.
    Hollander, David A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [50] Comment on: 'Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'
    Calugaru, D.
    Calugaru, M.
    EYE, 2016, 30 (05) : 766 - 766
12345